SHARE

Narayana Health targets higher UK margins by pivoting to private patients

Narayana Health is shifting its UK focus to private care, aiming to lift EBITDA margins from 10-10.5% to the high teens. The move supports a ₹3,000 crore expansion in India, adding 2,000 beds in key cities and targeting premium healthcare segments.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.